ADC measurements showed a significant correlation with tumor Gleason score at final pathology. The ADCratio demonstrated the best correlation compared to the ADCtumor value and radically improved accuracy in discriminating Gleason score ≤7(3+4) from Gleason score ≥7(4+3) tumors.

• Multiparametric MRI is an accurate diagnostic technique for preoperative prostate cancer staging • ECE risk scoring predicts extracapsular tumour extension at final pathology • ECE risk scoring shows an AUC of 0.86 on the ROC-curve • ECE risk scoring shows a moderate inter-reader agreement (K = 0.45) • Multiparametric MRI provides essential knowledge for optimal clinical management.

No abstract

. Background:  Intraocular silicone oil may migrate into the optic nerve or the cerebral ventricles, but little is known about the frequency of these events. The aim of this prospective neuroimaging study was to determine the frequency of extraocular silicone oil migration in humans operated for retinal detachment. Methods:  Nineteen patients included in this study were referred for silicone oil removal after uncomplicated retinal detachment surgery using internal silicone oil tamponade. Patients with a previous history of intraocular silicone oil, glaucoma or optic pit were excluded. After informed consent, the patients underwent magnetic resonance imaging (MRI). Fat saturation as well as short T1 inversion recovery (STIR) sequences combined with water saturation allowed silicone oil to be easily detectable. Results:  The mean delay between the silicone oil injection and the MRI procedure was 115 days. No extraocular silicone oil in the orbit, in the optic nerve or in the cerebral ventricles was found on MRI. Conclusions:  This is the first published in vivo study on the frequency of extraocular silicone oil migration after retinal detachment surgery. Special dedicated MRI sequences are able to accurately visualize intraocular silicone oil. None of the included 19 patients were detected with silicone oil migration into the visual pathways or intracranially, suggesting that its occurrence may be very rare, maybe only in patients with optic nerve head anatomical predispositions.

To evaluate the effect of a new oral manganese contrast agent (CMC-001) on magnetic resonance imaging (MRI) intensities at different magnetic field strengths. Twelve healthy volunteers underwent abdominal MRI 1 week before and within 2.5-4.5 h after CMC-001 (MnCl(2) and absorption promoters dissolved in water) intake at three different MR scanners of 0.23, 0.6 and 1.5 T. Image contrast and intensity enhancement of liver and pancreas were analysed relatively to muscle and fat intensities. Manganese blood levels were followed for 24 h. Whole-blood manganese concentration levels stayed within the normal range. The liver intensities on T2w images decreased about 10% for the 1/2 contrast dose and about 20% for the full contrast dose independent of the field strength. The liver intensities on T1w images increased more than 30% for 1/2 contrast dose and over 40% for full contrast dose. The maximum T1 enhancement was achieved at the highest field. Pancreas intensities were not affected. Contrast between liver, muscle and fat intensities increased with magnetic field, as well as standard errors of the volunteer-averaged intensities. Oral intake of CMC-001 influences liver intensities and does not affect pancreas intensities at different magnetic field strengths.